USANA HEALTH SCIENCES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
USANA HEALTH SCIENCES, INC. (USNA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $22.00 million for the 12-month period ending 2026-01-03, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-16
- USANA HEALTH SCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2026 was $22.00M, a 13.31% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $19.42M, a 1.57% increase from fiscal 2023.
- USANA HEALTH SCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $19.12M, a 5.16% increase from fiscal 2022.
- USANA HEALTH SCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $18.18M, a 2.04% decline from fiscal 2022.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2026-01-03 | $22.00M 10-K · filed 2026-03-16 |
| 2024-12-28 | $19.42M 10-K · filed 2025-03-12 |
| 2023-12-30 | $19.12M 10-K · filed 2024-02-27 |
| 2022-12-31 | $18.18M 10-K · filed 2023-02-28 |
| 2022-01-01 | $18.56M 10-K · filed 2022-03-01 |
| 2021-01-02 | $17.12M 10-K · filed 2021-03-02 |
| 2019-12-28 | $20.09M 10-K · filed 2020-02-25 |
| 2018-12-29 | $30.22M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |